A meta-analysis published in 2000 that included three large trials (SAVE, TRACE, AIRE) concluded that ACE inhibitors administered 48 h from the onset of AMI caused a decrease in mortality, a reduction in the risk of heart failure and the number of hospitalizations for this condition. Here, ACE is linked to heart failure.